▶ 調査レポート

腫瘍学分子診断の世界市場:市場規模・現状・予測

• 英文タイトル:Global Oncology Molecular Diagnostics Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。腫瘍学分子診断の世界市場:市場規模・現状・予測 / Global Oncology Molecular Diagnostics Market Size, Status and Forecast 2019-2025 / QYR9ST03702資料のイメージです。• レポートコード:QYR9ST03702
• 出版社/出版日:QYResearch / 2019年9月2日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、98ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
※当調査レポートでは、腫瘍学分子診断の世界市場について調査・分析し、腫瘍学分子診断の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別(PCR、INAAT、DNAシーケンシング及びNGS、インサイチュハイブリダイゼーション、DNAマイクロアレイ、その他)、用途別(感染症、腫瘍学、遺伝子検査、その他)、地域別(北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米)に区分して市場規模を算出しました。


・レポートの概要
・世界の腫瘍学分子診断市場動向
・主要企業別マーケットシェア
・腫瘍学分子診断の種類別市場規模2014-2019
(PCR、INAAT、DNAシーケンシング及びNGS、インサイチュハイブリダイゼーション、DNAマイクロアレイ、その他)
・腫瘍学分子診断の用途別市場規模2014-2019
(感染症、腫瘍学、遺伝子検査、その他)
・腫瘍学分子診断の北米市場:主要企業・種類別/用途別市場規模
・腫瘍学分子診断のヨーロッパ市場:主要企業・種類別/用途別市場規模
・腫瘍学分子診断の中国市場:主要企業・種類別/用途別市場規模
・腫瘍学分子診断の日本国内市場:主要企業・種類別/用途別市場規模
・腫瘍学分子診断の東南アジア市場:主要企業・種類別/用途別市場規模
・腫瘍学分子診断のインド市場:主要企業・種類別/用途別市場規模
・腫瘍学分子診断の中南米市場:主要企業・種類別/用途別市場規模
・主要企業のプロフィール
(Abbott Laboratories、Bayer Healthcare、Beckton Dickinson、Cepheid、Dako、Danaher、Gen Probe、Qiagen、Roche Diagnostics、Siemens、Sysmex)
・腫瘍学分子診断の市場規模予測2019-2025
(種類別、用途別、地域別市場予測)
・アナリストの観点・結論
...

Molecular diagnostics is one of the most transformative and dynamic areas of diagnostics. It is a technique used for analyzing biological markers in proteome and genome. Molecular diagnostics tests are increasingly used in oncology, infectious disease, pharmacogenomics, and human leukocyte antigen typing. Oncology molecular diagnostics is a major application of molecular biology and is increasingly used for cancer screening, therapy selection, diagnosis, and relapse monitoring. Some of the major that are diagnosed and treated by molecular diagnostics are breast, ovarian, cervical, head and neck, pancreatic, colorectal, brain, prostate, lung, and endometrial cancers.
In 2018, the global Oncology Molecular Diagnostics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Oncology Molecular Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Oncology Molecular Diagnostics development in United States, Europe and China.

The key players covered in this study
Abbott Laboratories
Bayer Healthcare
Beckton Dickinson
Cepheid
Dako
Danaher
Gen Probe
Qiagen
Roche Diagnostics
Siemens
Sysmex

Market segment by Type, the product can be split into
PCR
INAAT
DNA sequencing & NGS
In situ hybridization
DNA microarrays
Other

Market segment by Application, split into
Infectious diseases
oncology
Genetic tests
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Oncology Molecular Diagnostics status, future forecast, growth opportunity, key market and key players.
To present the Oncology Molecular Diagnostics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Oncology Molecular Diagnostics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Oncology Molecular Diagnostics Market Size Growth Rate by Type (2014-2025)
1.4.2 PCR
1.4.3 INAAT
1.4.4 DNA sequencing & NGS
1.4.5 In situ hybridization
1.4.6 DNA microarrays
1.4.7 Other
1.5 Market by Application
1.5.1 Global Oncology Molecular Diagnostics Market Share by Application (2014-2025)
1.5.2 Infectious diseases
1.5.3 oncology
1.5.4 Genetic tests
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Oncology Molecular Diagnostics Market Size
2.2 Oncology Molecular Diagnostics Growth Trends by Regions
2.2.1 Oncology Molecular Diagnostics Market Size by Regions (2014-2025)
2.2.2 Oncology Molecular Diagnostics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Oncology Molecular Diagnostics Market Size by Manufacturers
3.1.1 Global Oncology Molecular Diagnostics Revenue by Manufacturers (2014-2019)
3.1.2 Global Oncology Molecular Diagnostics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Oncology Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2 Oncology Molecular Diagnostics Key Players Head office and Area Served
3.3 Key Players Oncology Molecular Diagnostics Product/Solution/Service
3.4 Date of Enter into Oncology Molecular Diagnostics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Oncology Molecular Diagnostics Market Size by Type (2014-2019)
4.2 Global Oncology Molecular Diagnostics Market Size by Application (2014-2019)

5 United States
5.1 United States Oncology Molecular Diagnostics Market Size (2014-2019)
5.2 Oncology Molecular Diagnostics Key Players in United States
5.3 United States Oncology Molecular Diagnostics Market Size by Type
5.4 United States Oncology Molecular Diagnostics Market Size by Application

6 Europe
6.1 Europe Oncology Molecular Diagnostics Market Size (2014-2019)
6.2 Oncology Molecular Diagnostics Key Players in Europe
6.3 Europe Oncology Molecular Diagnostics Market Size by Type
6.4 Europe Oncology Molecular Diagnostics Market Size by Application

7 China
7.1 China Oncology Molecular Diagnostics Market Size (2014-2019)
7.2 Oncology Molecular Diagnostics Key Players in China
7.3 China Oncology Molecular Diagnostics Market Size by Type
7.4 China Oncology Molecular Diagnostics Market Size by Application

8 Japan
8.1 Japan Oncology Molecular Diagnostics Market Size (2014-2019)
8.2 Oncology Molecular Diagnostics Key Players in Japan
8.3 Japan Oncology Molecular Diagnostics Market Size by Type
8.4 Japan Oncology Molecular Diagnostics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Oncology Molecular Diagnostics Market Size (2014-2019)
9.2 Oncology Molecular Diagnostics Key Players in Southeast Asia
9.3 Southeast Asia Oncology Molecular Diagnostics Market Size by Type
9.4 Southeast Asia Oncology Molecular Diagnostics Market Size by Application

10 India
10.1 India Oncology Molecular Diagnostics Market Size (2014-2019)
10.2 Oncology Molecular Diagnostics Key Players in India
10.3 India Oncology Molecular Diagnostics Market Size by Type
10.4 India Oncology Molecular Diagnostics Market Size by Application

11 Central & South America
11.1 Central & South America Oncology Molecular Diagnostics Market Size (2014-2019)
11.2 Oncology Molecular Diagnostics Key Players in Central & South America
11.3 Central & South America Oncology Molecular Diagnostics Market Size by Type
11.4 Central & South America Oncology Molecular Diagnostics Market Size by Application

12 International Players Profiles
12.1 Abbott Laboratories
12.1.1 Abbott Laboratories Company Details
12.1.2 Company Description and Business Overview
12.1.3 Oncology Molecular Diagnostics Introduction
12.1.4 Abbott Laboratories Revenue in Oncology Molecular Diagnostics Business (2014-2019)
12.1.5 Abbott Laboratories Recent Development
12.2 Bayer Healthcare
12.2.1 Bayer Healthcare Company Details
12.2.2 Company Description and Business Overview
12.2.3 Oncology Molecular Diagnostics Introduction
12.2.4 Bayer Healthcare Revenue in Oncology Molecular Diagnostics Business (2014-2019)
12.2.5 Bayer Healthcare Recent Development
12.3 Beckton Dickinson
12.3.1 Beckton Dickinson Company Details
12.3.2 Company Description and Business Overview
12.3.3 Oncology Molecular Diagnostics Introduction
12.3.4 Beckton Dickinson Revenue in Oncology Molecular Diagnostics Business (2014-2019)
12.3.5 Beckton Dickinson Recent Development
12.4 Cepheid
12.4.1 Cepheid Company Details
12.4.2 Company Description and Business Overview
12.4.3 Oncology Molecular Diagnostics Introduction
12.4.4 Cepheid Revenue in Oncology Molecular Diagnostics Business (2014-2019)
12.4.5 Cepheid Recent Development
12.5 Dako
12.5.1 Dako Company Details
12.5.2 Company Description and Business Overview
12.5.3 Oncology Molecular Diagnostics Introduction
12.5.4 Dako Revenue in Oncology Molecular Diagnostics Business (2014-2019)
12.5.5 Dako Recent Development
12.6 Danaher
12.6.1 Danaher Company Details
12.6.2 Company Description and Business Overview
12.6.3 Oncology Molecular Diagnostics Introduction
12.6.4 Danaher Revenue in Oncology Molecular Diagnostics Business (2014-2019)
12.6.5 Danaher Recent Development
12.7 Gen Probe
12.7.1 Gen Probe Company Details
12.7.2 Company Description and Business Overview
12.7.3 Oncology Molecular Diagnostics Introduction
12.7.4 Gen Probe Revenue in Oncology Molecular Diagnostics Business (2014-2019)
12.7.5 Gen Probe Recent Development
12.8 Qiagen
12.8.1 Qiagen Company Details
12.8.2 Company Description and Business Overview
12.8.3 Oncology Molecular Diagnostics Introduction
12.8.4 Qiagen Revenue in Oncology Molecular Diagnostics Business (2014-2019)
12.8.5 Qiagen Recent Development
12.9 Roche Diagnostics
12.9.1 Roche Diagnostics Company Details
12.9.2 Company Description and Business Overview
12.9.3 Oncology Molecular Diagnostics Introduction
12.9.4 Roche Diagnostics Revenue in Oncology Molecular Diagnostics Business (2014-2019)
12.9.5 Roche Diagnostics Recent Development
12.10 Siemens
12.10.1 Siemens Company Details
12.10.2 Company Description and Business Overview
12.10.3 Oncology Molecular Diagnostics Introduction
12.10.4 Siemens Revenue in Oncology Molecular Diagnostics Business (2014-2019)
12.10.5 Siemens Recent Development
12.11 Sysmex

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Oncology Molecular Diagnostics Key Market Segments
Table Key Players Oncology Molecular Diagnostics Covered
Table Global Oncology Molecular Diagnostics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Oncology Molecular Diagnostics Market Size Market Share by Type 2014-2025
Figure PCR Figures
Table Key Players of PCR
Figure INAAT Figures
Table Key Players of INAAT
Figure DNA sequencing & NGS Figures
Table Key Players of DNA sequencing & NGS
Figure In situ hybridization Figures
Table Key Players of In situ hybridization
Figure DNA microarrays Figures
Table Key Players of DNA microarrays
Figure Other Figures
Table Key Players of Other
Table Global Oncology Molecular Diagnostics Market Size Growth by Application 2014-2025 (Million US$)
Figure Infectious diseases Case Studies
Figure oncology Case Studies
Figure Genetic tests Case Studies
Figure Other Case Studies
Figure Oncology Molecular Diagnostics Report Years Considered
Table Global Oncology Molecular Diagnostics Market Size 2014-2025 (Million US$)
Figure Global Oncology Molecular Diagnostics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Oncology Molecular Diagnostics Market Size by Regions 2014-2025 (Million US$)
Table Global Oncology Molecular Diagnostics Market Size by Regions 2014-2019 (Million US$)
Table Global Oncology Molecular Diagnostics Market Share by Regions 2014-2019
Figure Global Oncology Molecular Diagnostics Market Share by Regions 2014-2019
Figure Global Oncology Molecular Diagnostics Market Share by Regions 2019
Table Market Top Trends
Table Global Oncology Molecular Diagnostics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Oncology Molecular Diagnostics Market Share by Manufacturers (2014-2019)
Figure Global Oncology Molecular Diagnostics Market Share by Manufacturers in 2018
Table Global Oncology Molecular Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Oncology Molecular Diagnostics Product/Solution/Service
Table Date of Enter into Oncology Molecular Diagnostics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Oncology Molecular Diagnostics Market Size by Type (2014-2019) (Million US$)
Table Global Oncology Molecular Diagnostics Market Size Share by Type (2014-2019)
Figure Global Oncology Molecular Diagnostics Market Size Market Share by Type (2014-2019)
Table Global Oncology Molecular Diagnostics Market Size by Application (2014-2019) (Million US$)
Table Global Oncology Molecular Diagnostics Market Size Share by Application (2014-2019)
Figure Global Oncology Molecular Diagnostics Market Size Market Share by Application (2014-2019)
Figure Global Oncology Molecular Diagnostics Revenue Market Share by Application in 2018
Figure United States Oncology Molecular Diagnostics Market Size 2014-2019 (Million US$)
Table United States Key Players Oncology Molecular Diagnostics Revenue (2018-2019) (Million US$)
Table United States Key Players Oncology Molecular Diagnostics Market Share (2018-2019)
Table United States Oncology Molecular Diagnostics Market Size by Type (2014-2019) (Million US$)
Table United States Oncology Molecular Diagnostics Market Share by Type (2014-2019)
Table United States Oncology Molecular Diagnostics Market Size by Application (2014-2019) (Million US$)
Table United States Oncology Molecular Diagnostics Market Share by Application (2014-2019)
Figure Europe Oncology Molecular Diagnostics Market Size 2014-2019 (Million US$)
Table Europe Key Players Oncology Molecular Diagnostics Revenue (2018-2019) (Million US$)
Table Europe Key Players Oncology Molecular Diagnostics Market Share (2018-2019)
Table Europe Oncology Molecular Diagnostics Market Size by Type (2014-2019) (Million US$)
Table Europe Oncology Molecular Diagnostics Market Share by Type (2014-2019)
Table Europe Oncology Molecular Diagnostics Market Size by Application (2014-2019) (Million US$)
Table Europe Oncology Molecular Diagnostics Market Share by Application (2014-2019)
Figure China Oncology Molecular Diagnostics Market Size 2014-2019 (Million US$)
Table China Key Players Oncology Molecular Diagnostics Revenue (2018-2019) (Million US$)
Table China Key Players Oncology Molecular Diagnostics Market Share (2018-2019)
Table China Oncology Molecular Diagnostics Market Size by Type (2014-20189) (Million US$)
Table China Oncology Molecular Diagnostics Market Share by Type (2014-2019)
Table China Oncology Molecular Diagnostics Market Size by Application (2014-2019) (Million US$)
Table China Oncology Molecular Diagnostics Market Share by Application (2014-2019)
Figure Japan Oncology Molecular Diagnostics Market Size 2014-2019 (Million US$)
Table Japan Key Players Oncology Molecular Diagnostics Revenue (2018-2019) (Million US$)
Table Japan Key Players Oncology Molecular Diagnostics Market Share (2018-2019)
Table Japan Oncology Molecular Diagnostics Market Size by Type (2014-2019) (Million US$)
Table Japan Oncology Molecular Diagnostics Market Share by Type (2014-2019)
Table Japan Oncology Molecular Diagnostics Market Size by Application (2014-2019) (Million US$)
Table Japan Oncology Molecular Diagnostics Market Share by Application (2014-2019)
Figure Southeast Asia Oncology Molecular Diagnostics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Oncology Molecular Diagnostics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Oncology Molecular Diagnostics Market Share (2018-2019)
Table Southeast Asia Oncology Molecular Diagnostics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Oncology Molecular Diagnostics Market Share by Type (2014-2019)
Table Southeast Asia Oncology Molecular Diagnostics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Oncology Molecular Diagnostics Market Share by Application (2014-2019)
Figure India Oncology Molecular Diagnostics Market Size 2014-2019 (Million US$)
Table India Key Players Oncology Molecular Diagnostics Revenue (2018-2019) (Million US$)
Table India Key Players Oncology Molecular Diagnostics Market Share (2018-2019)
Table India Oncology Molecular Diagnostics Market Size by Type (2014-2019) (Million US$)
Table India Oncology Molecular Diagnostics Market Share by Type (2014-2019)
Table India Oncology Molecular Diagnostics Market Size by Application (2014-2019) (Million US$)
Table India Oncology Molecular Diagnostics Market Share by Application (2014-2019)
Figure Central & South America Oncology Molecular Diagnostics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Oncology Molecular Diagnostics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Oncology Molecular Diagnostics Market Share (2018-2019)
Table Central & South America Oncology Molecular Diagnostics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Oncology Molecular Diagnostics Market Share by Type (2014-2019)
Table Central & South America Oncology Molecular Diagnostics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Oncology Molecular Diagnostics Market Share by Application (2014-2019)
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in Oncology Molecular Diagnostics Business (2014-2019) (Million US$)
Figure Abbott Laboratories Revenue Growth Rate in Oncology Molecular Diagnostics Business (2014-2019)
Table Abbott Laboratories Recent Development
Table Bayer Healthcare Company Details
Table Bayer Healthcare Revenue in Oncology Molecular Diagnostics Business (2014-2019)(Million US$)
Figure Bayer Healthcare Revenue Growth Rate in Oncology Molecular Diagnostics Business (2014-2019)
Table Bayer Healthcare Recent Development
Table Beckton Dickinson Company Details
Table Beckton Dickinson Revenue in Oncology Molecular Diagnostics Business (2014-2019)(Million US$)
Figure Beckton Dickinson Revenue Growth Rate in Oncology Molecular Diagnostics Business (2014-2019)
Table Beckton Dickinson Recent Development
Table Cepheid Company Details
Table Cepheid Revenue in Oncology Molecular Diagnostics Business (2014-2019)(Million US$)
Figure Cepheid Revenue Growth Rate in Oncology Molecular Diagnostics Business (2014-2019)
Table Cepheid Recent Development
Table Dako Company Details
Table Dako Revenue in Oncology Molecular Diagnostics Business (2014-2019)(Million US$)
Figure Dako Revenue Growth Rate in Oncology Molecular Diagnostics Business (2014-2019)
Table Dako Recent Development
Table Danaher Company Details
Table Danaher Revenue in Oncology Molecular Diagnostics Business (2014-2019)(Million US$)
Figure Danaher Revenue Growth Rate in Oncology Molecular Diagnostics Business (2014-2019)
Table Danaher Recent Development
Table Gen Probe Company Details
Table Gen Probe Revenue in Oncology Molecular Diagnostics Business (2014-2019)(Million US$)
Figure Gen Probe Revenue Growth Rate in Oncology Molecular Diagnostics Business (2014-2019)
Table Gen Probe Recent Development
Table Qiagen Company Details
Table Qiagen Revenue in Oncology Molecular Diagnostics Business (2014-2019)(Million US$)
Figure Qiagen Revenue Growth Rate in Oncology Molecular Diagnostics Business (2014-2019)
Table Qiagen Recent Development
Table Roche Diagnostics Company Details
Table Roche Diagnostics Revenue in Oncology Molecular Diagnostics Business (2014-2019)(Million US$)
Figure Roche Diagnostics Revenue Growth Rate in Oncology Molecular Diagnostics Business (2014-2019)
Table Roche Diagnostics Recent Development
Table Siemens Company Details
Table Siemens Revenue in Oncology Molecular Diagnostics Business (2014-2019)(Million US$)
Figure Siemens Revenue Growth Rate in Oncology Molecular Diagnostics Business (2014-2019)
Table Siemens Recent Development
Table Sysmex Company Details
Table Global Oncology Molecular Diagnostics Market Size by Regions (Million US$) 2019-2025
Figure Global Oncology Molecular Diagnostics Market Size Share by Regions (2019-2025)
Figure Global Oncology Molecular Diagnostics Market Size Share by Regions in 2025
Figure United States Oncology Molecular Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Oncology Molecular Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure China Oncology Molecular Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Oncology Molecular Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Oncology Molecular Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure India Oncology Molecular Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Oncology Molecular Diagnostics Market Size Forecast (2019-2025)(Million USD)
Table Global Oncology Molecular Diagnostics Market Size by Product (2019-2025) (Million US$)
Figure Global Oncology Molecular Diagnostics Market Size by Product (2019-2025)
Figure Global Oncology Molecular Diagnostics Market Size by Product in 2025
Table Global Oncology Molecular Diagnostics Market Size by Application (2019-2025) (Million US$)
Figure Global Oncology Molecular Diagnostics Market Size by Application (2019-2025)
Figure Global Oncology Molecular Diagnostics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources